FDA Webview
X

Free FDA Notices

FDA Withdraws Bayer’s NADA for Enrofloxacin

08/01/2005

Federal Register Final rule: FDA is amending the animal drug regulations by removing the portions reflecting approval of a new animal drug application (NADA) for which FDA has withdrawn approval. NADA 140-828, sponsored by Bayer Corp., for using enrofloxacin to treat poultry. To view this final rule, click here.

LATEST NEWS